# Lifecore Biomedical to be acquired by Webster Equity Partners for up to $663.7M

Lifecore Biomedical has entered into a definitive agreement to be acquired by Webster Equity Partners in a transaction valued at up to $663.7 million, including contingent value rights. Common stockholders will receive $6.28 per share in cash.

- Type: Acquisition
- Announced: 2026-09-28
- Where: Chaska, Minnesota, United States
- Value: $663.7M
- Status: announced
- Products: contract development and manufacturing (CDMO) services
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Webster Equity Partners](https://endata.com/companies/94346.md) (acquirer)
- [Lifecore Biomedical](https://endata.com/companies/94347.md) (target)

## Sources

- [globenewswire.com](https://www.globenewswire.com/de/news-release/2026/9/28/3369877/23089/en/lifecore-biomedical-to-be-acquired-by-webster-equity-partners.html), 2026-09-28: "Lifecore is approaching an exciting inflection point, with the potential for numerous programs to commercialize by the end of 2028."
- [ir.lifecore.com](https://ir.lifecore.com/news-releases/news-release-details/lifecore-biomedical-be-acquired-webster-equity-partners), 2026-09-28: "We are thrilled to announce this exciting transaction which we believe will support Lifecore's next phase of growth."
- [app.readthrough.bio](https://app.readthrough.bio/stories/lifecore-biomedical-to-be-acquired-by-webster-equity-partners-50c69d), 2026-09-29: "Lifecore Biomedical, Inc. said on September 28, 2026 that it signed a definitive agreement for Webster Equity Partners to acquire the company."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.